ProQR Therapeutics (PRQR)
(Delayed Data from NSDQ)
$2.10 USD
-0.09 (-4.11%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $2.11 +0.01 (0.48%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
ProQR Therapeutics N.V.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
PRQR 2.10 -0.09(-4.11%)
Will PRQR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PRQR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PRQR
Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Beats Revenue Estimates
Techne (TECH) Q3 Earnings and Revenues Beat Estimates
PRQR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Strength Seen in BioNTech (BNTX): Can Its 6.0% Jump Turn into More Strength?
ProQR (PRQR) Reports Q4 Loss, Lags Revenue Estimates
Krystal Biotech, Inc. (KRYS) Beats Q3 Earnings and Revenue Estimates
Other News for PRQR
Is PRQR positioned for a breakdown? Non-ADX 1,2,3,4 Bearish shows up after sinking 4.11%
Crossed Above 200 Day Moving Average appears for PRQR after 6.31% move
PRQR rises 3.52% on September 18, leaving the technical picture intact
MACD Bearish Centerline Cross appears for PRQR after 0.25% move
Fell Below 200 Day Moving Average appears for PRQR after 9.36% move